A Preference-Based Value Assessment of the Fear of COVID-19 Contagion

References

• Mertens G, Gerritsen L, Duijndam S, Salemink E, Engelhard IM. Fear of the coronavirus (COVID-19): predictors in an online study conducted in March 2020. J Anxiety Disord. 2020;74:102258. doi:10.1016/j.janxdis.2020.102258
   PubMed Web of Science ®Google Scholar
• Meisenhelder JB, LaCharite C. Fear of contagion: the public response to AIDS. Image J Nurs Sch. 1989;21(1):7–9. doi:10.1111/j.1547-5069.1989.tb00089.x
   PubMedGoogle Scholar
• Azim D, Kumar S, Nasim S, Arif TB, Nanjiani D. COVID-19 as a psychological contagion: a new Pandora’s box to close? Infect Control Hosp Epidemiol. 2020;41(8):989–990.
   PubMed Web of Science ®Google Scholar
• Meisenhelder JB, LaCharite CL. Fear of contagion: a stress response to acquired immunodeficiency syndrome. ANS Adv Nurs Sci. 1989;11(2):29–38. doi:10.1097/00012272-198901000-00007
   PubMed Web of Science ®Google Scholar
• Schimmenti A, Billieux J, Starcevic V. The four horsemen of fear: an integrated model of understanding fear experiences during the Covid-19 pandemic. Clin Neuropsychiatr. 2020;17(2):41–45. doi:10.36131/CN20200202
   PubMed Web of Science ®Google Scholar
• Muller AE, Himmels JPW, Van de Velde S. Instruments to measure fear of COVID-19: a diagnostic systematic review. BMC Med Res Methodol. 2021;21(1):82. doi:10.1186/s12874-021-01262-5
   PubMed Web of Science ®Google Scholar
• Costanza A, Macheret L, Folliet A, et al. COVID-19 related fears of patients admitted to a psychiatric emergency department during and post-lockdown in Switzerland: preliminary findings to look ahead for tailored preventive mental health strategies. Medicina. 2021;57(12):12. doi:10.3390/medicina57121360
   Google Scholar
• Şimşir Z, Koç H, Seki T, Griffiths MD. The relationship between fear of COVID-19 and mental health problems: a meta-analysis. Death Stud. 2022;46(3):515–523. doi:10.1080/07481187.2021.1889097
   PubMed Web of Science ®Google Scholar
• Nouvellet P, Bhatia S, Cori A, et al. Reduction in mobility and COVID-19 transmission. Nat Commun. 2021;12(1):1090. doi:10.1038/s41467-021-21358-2
   PubMed Web of Science ®Google Scholar
• Blandin A, Bick A Real-time labour market estimates during the 2020 coronavirus outbreak. Available from: https://cepr.org/voxeu/columns/real-time-labour-market-estimates-during-2020-coronavirus-outbreak#:~:text=Our%20estimates%2C%20summarised%20in%20Bick,April%20(see%20Figure%201. Accessed May 6, 2020.
   Google Scholar
• Kamal-Bahl S, Willke RJ, Puckett JT, Doshi JA The case for using novel value elements when assessing COVID-19 vaccines and therapeutics. Health Affairs Blog. Available from: https://www.healthaffairs.org/content/forefront/case-using-novel-value-elements-assessing-covid-19-vaccines-and-therapeutics. Accessed June 23, 2020.
   Google Scholar
• Amerio A, Odone A, Marzano L, et al. Covid-19: the last call for telepsychiatry. Acta Biomed. 2020;91:3.
   Google Scholar
• Lakdawalla DN, Doshi JA, Garrison LP, Phelps CE, Basu A, Danzon PM. Defining elements of value in health care-a health economics approach: an ISPOR special task force report [3]. Value Health. 2018;21(2):131–139. doi:10.1016/j.jval.2017.12.007
   PubMed Web of Science ®Google Scholar
• Andersson O, Campos-Mercade P, Meier AN, Wengström E. Anticipation of COVID-19 vaccines reduces willingness to socially distance. J Health Econ. 2021;80:102530. doi:10.1016/j.jhealeco.2021.102530
   PubMed Web of Science ®Google Scholar
• Kohli M, Maschio M, Becker D, Weinstein MC. The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: use of cost-effectiveness modeling to inform vaccination prioritization. Vaccine. 2021;39(7):1157–1164. doi:10.1016/j.vaccine.2020.12.078
   PubMed Web of Science ®Google Scholar
• Emond SK, Pearson SD Alternative policies for pricing novel vaccines and drug therapies for COVID-19. Available from: https://icer.org/wp-content/uploads/2021/04/Alternative-Policies-for-Pricing-Novel-Vaccines-and-Drug-Therapies-for-COVID-19-_-ICER-White-Paper.pdf. Acessed June 1, 2020.
   Google Scholar
• The Council of Economic Advisers. Evaluating the effects of the economic response to COVID-19. 2020. Available from: https://trumpwhitehouse.archives.gov/wp-content/uploads/2020/08/Evaluating-The-Effects-of-The-Economic-Response-to-COVID-19.pdf. Acessed June 1, 2020.
   Google Scholar
• Adler MD. Fear assessment: cost-benefit analysis and the pricing of fear and anxiety. Chi Kent L Rev. 2004;79:977.
   Google Scholar
• Fisman DN, Mittleman MA, Sorock GS, Harris AD. Willingness to pay to avoid sharps-related injuries: a study in injured health care workers. Am J Infect Control. 2002;30(5):283–287. doi:10.1067/mic.2002.124586
   PubMed Web of Science ®Google Scholar
• Hanley N, Mourato S, Wright RE. Choice modelling approaches: a superior alternative for environmental valuatioin? J Econ Surv. 2001;15(3):435–462. doi:10.1111/1467-6419.00145
   Web of Science ®Google Scholar
• Mahieu P-A, Andersson H, Beaumais O, Crastes R, Wolff F-C Is choice experiment becoming more popular than contingent valuation? A systematic review in agriculture, environment and health. FAERE Working Paper, 2014.12.
   Google Scholar
• Green C, Gerard K. Exploring the social value of health-care interventions: a stated preference discrete choice experiment. Health Econ. 2009;18(8):951–976. doi:10.1002/hec.1414
   PubMed Web of Science ®Google Scholar
• Soekhai V, de Bekker-Grob EW, Ellis AR, Vass CM. Discrete choice experiments in health economics: past, present and future. Pharmacoeconomics. 2019;37(2):201–226. doi:10.1007/s40273-018-0734-2
   PubMed Web of Science ®Google Scholar
• Cleland J, Porteous T, Skåtun D. What can discrete choice experiments do for you? Med Educ. 2018;52(11):1113–1124. doi:10.1111/medu.13657
   PubMed Web of Science ®Google Scholar
• Sudeh C-S, Arne Risa H, Nicola M, et al. What patients want from primary care consultations: a discrete choice experiment to identify patients’ priorities. Ann Fam Med. 2008;6(2):107. doi:10.1370/afm.816
   PubMed Web of Science ®Google Scholar
• Reed SD, Yang JC, Gonzalez JM, Johnson FR. Quantifying value of hope. Value Health. 2021;24(10):1511–1519. doi:10.1016/j.jval.2021.04.1284
   PubMed Web of Science ®Google Scholar
• Hauber AB, González JM, Groothuis-Oudshoorn CGM, et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis good research practices task force. Value Health. 2016;19(4):300–315. doi:10.1016/j.jval.2016.04.004
   PubMed Web of Science ®Google Scholar
• Reed Johnson F, Lancsar E, Marshall D, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force. Value Health. 2013;16(1):3–13. doi:10.1016/j.jval.2012.08.2223
   PubMed Web of Science ®Google Scholar
• U.S. Food & Drug Administration. Fact sheet for healthcare providers administering vaccine (vaccination providers) emergency use authorization (EUA) of the Janssen Covid-19 vaccine to prevent coronavirus disease 2019 (Covid-19). Available from: https://www.fda.gov/media/144637/download. Accessed October 17, 2021.
   Google Scholar
• U.S. Food & Drug Administration. Fact sheet for healthcare providers administering vaccine (vaccination providers) emergency use authorization (EUA) of the Moderna covid-19 vaccine to prevent coronavirus disease 2019 (Covid-19). Available from: https://www.fda.gov/media/144637/download. Accessed October 17, 2021.
   Google Scholar
• U.S. Food & Drug Administration. Fact sheet for healthcare providers administering vaccine (vaccination providers) emergency use authorization (EUA) of the Pfizer-BioNTech covid-19 vaccine to prevent coronavirus disease 2019 (Covid-19). Available from: https://www.fda.gov/media/144413/download. Accessed October 17, 2021.
   Google Scholar
• Centers for Disease Control and Prevention. COVID data tracker. Available from: https://covid.cdc.gov/covid-data-tracker/#datatracker-home. Accessed January 5, 2022.
   Google Scholar
• Havers FP, Pham H, Taylor CA, et al. COVID-19-associated hospitalizations among vaccinated and unvaccinated adults 18 years or older in 13 US States, January 2021 to April 2022. JAMA Int Med. 2022;182(10):1071–1081. doi:10.1001/jamainternmed.2022.4299
   PubMed Web of Science ®Google Scholar
• Kow CS, Hasan SS. Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies. Inflammopharmacology. 2021;29(4):1075–1090. doi:10.1007/s10787-021-00839-2
   PubMed Web of Science ®Google Scholar
• Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. NEJM. 2020;383(27):2603–2615. doi:10.1056/NEJMoa2034577
   PubMed Web of Science ®Google Scholar
• The White House. COVID-19 press briefing. Available from: https://www.whitehouse.gov/wp-content/uploads/2021/08/COVID-Press-Briefing_24August2021_for-transcript.pdf. Accessed August 5, 2021.
   Google Scholar
• Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. 2021;21(10):626–636. doi:10.1038/s41577-021-00592-1
   PubMed Web of Science ®Google Scholar
• Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making: a user’s guide. Pharmacoeconomics. 2008;26(8):661–677. doi:10.2165/00019053-200826080-00004
   PubMed Web of Science ®Google Scholar
• Cartaxo ANS, Barbosa FIC, De souza bermejo PH, Moreira MF, Prata DN, Xue B. The exposure risk to COVID-19 in most affected countries: a vulnerability assessment model. PLoS One. 2021;16(3):e0248075. doi:10.1371/journal.pone.0248075
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Interim Guidance for Managing Healthcare Personnel with SARS-CoV-2 Infection or Exposure to SARS-CoV-2. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html. Accessed May 15, 2021.
   Google Scholar
• COVID-19 Event Risk Tool. USA risk assessment by county. Available from: https://covid19risk.biosci.gatech.edu/. Accessed April 6, 2021.
   Google Scholar
• Eisenstein M What’s your risk of catching COVID? These tools help you to find out. Available from: https://www.nature.com/articles/d41586-020-03637-y. Accessed April 6, 2021.
   Google Scholar
• Ioannidis JPA. Benefit of COVID-19 vaccination accounting for potential risk compensation. Npj Vaccines. 2021;6(1):99. doi:10.1038/s41541-021-00362-z
   PubMed Web of Science ®Google Scholar
• Sun Z, Di L, Sprigg W, Tong D, Casal M. Community venue exposure risk estimator for the COVID-19 pandemic. Health Place. 2020;66:102450. doi:10.1016/j.healthplace.2020.102450
   PubMed Web of Science ®Google Scholar
• Rowen D, Stevens K, Labeit A, et al. Using a discrete-choice experiment involving cost to value a classification system measuring the quality-of-life impact of self-management for diabetes. Value Health. 2018;21(1):69–77. doi:10.1016/j.jval.2017.06.016
   PubMed Web of Science ®Google Scholar
• Echazu L, Nocetti DC. Willingness to pay for morbidity and mortality risk reductions during an epidemic. Theory and preliminary evidence from COVID-19. Geneva Risk Insur Rev. 2020;45(2):114–133. doi:10.1057/s10713-020-00053-0
   PubMed Web of Science ®Google Scholar
• Bliemer MCJ, Rose JM. Construction of experimental designs for mixed logit models allowing for correlation across choice observations. Trans Res B Meth. 2010;44(6):720–734. doi:10.1016/j.trb.2009.12.004
   Web of Science ®Google Scholar
• Milte R, Ratcliffe J, Miller M, Whitehead C, Cameron ID, Crotty M. What are frail older people prepared to endure to achieve improved mobility following hip fracture? A discrete choice experiment. J Rehabil Med. 2013;45(1):81–86. doi:10.2340/16501977-1054
   PubMed Web of Science ®Google Scholar
• Nieboer AP, Koolman X, Stolk EA. Preferences for long-term care services: willingness to pay estimates derived from a discrete choice experiment. Soc Sci Med. 2010;70(9):1317–1325. doi:10.1016/j.socscimed.2009.12.027
   PubMed Web of Science ®Google Scholar
• Özdemir S, Johnson FR, Hauber AB. Hypothetical bias, cheap talk, and stated willingness to pay for health care. J Health Econ. 2009;28(4):894–901. doi:10.1016/j.jhealeco.2009.04.004
   PubMed Web of Science ®Google Scholar
• de Bekker-Grob EW, Donkers B, Jonker MF, Stolk EA. Sample size requirements for discrete-choice experiments in healthcare: a practical guide. Patient. 2015;8(5):373–384. doi:10.1007/s40271-015-0118-z
   PubMedGoogle Scholar
• Rose JM, Bliemer MCJ. Sample size requirements for stated choice experiments. Transportation. 2013;40(5):1021–1041. doi:10.1007/s11116-013-9451-z
   Web of Science ®Google Scholar
• Krinsky I, Robb AL. On approximating the statistical properties of elasticities. Rev Econ Stat. 1986;68(4):715–719. doi:10.2307/1924536
   Web of Science ®Google Scholar
• Çıkrıkçı Ö, Çıkrıkçı N, Griffiths M. Fear of COVID-19, stress and depression: a meta-analytic test of the mediating role of anxiety. Psychol Psychother. 2022;95(4):853–874. doi:10.1111/papt.12406
   PubMed Web of Science ®Google Scholar
• Heiat M, Heiat F, Halaji M, et al. Phobia and Fear of COVID-19: origins, complications and management, a narrative review. Ann Ig. 2021;33(4):360–370. doi:10.7416/ai.2021.2446
   PubMed Web of Science ®Google Scholar
• Wasim A, Truong J, Bakshi S, Majid U. A systematic review of fear, stigma, and mental health outcomes of pandemics. J Ment Health. 2023;32(5):920–934. doi:10.1080/09638237.2022.2091754
   PubMed Web of Science ®Google Scholar
• Catma S, Varol S. Willingness to pay for a hypothetical COVID-19 vaccine in the United States: a contingent valuation approach. Vaccines. 2021;9(4):4. doi:10.3390/vaccines9040318
   Web of Science ®Google Scholar
• Zhou L, Yan W, Li S, et al. Cost-effectiveness of interventions for the prevention and control of COVID-19: systematic review of 85 modelling studies. J Glob Health. 2022;12:05022. doi:10.7189/jogh.12.05022
   PubMed Web of Science ®Google Scholar